Episode 37: AI for psychotherapy. With Lindsay McKean, Psychotherapist ..read more

The liver is a miracle of physiology, with over 1,000 known functions. This highlights the potential impact of liver dysfunction on various bodily systems. Also, liver disease is a major cause of death globally, and the numbers are on the rise. This adds up to a critical clinical need. Dr Neil Guha is Professor of Hepatology at the University of Nottingham, an NHS consultant and Research scientist. He recently published an excellent paper in the journal of medical AI on a ML model to rate risk for liver disease ..read more

A year ago, very soon after the release of ChatGPT there was an article in Nature with the curious title… ChatGPT listed as author on research papers: many scientists disapprove Since then, the use of LLMs in medical research has exploded, including as a coauthor of articles. But how is it being used? Does it matter? Does it undermine the human authors? And does it risk the quality of the research? With me to discuss this is a brilliant up and coming researcher at the Universal Scientific Education and Research Network, Fiona Morrison ..read more

Anitha Kannan is a founding member and the head of machine learning at Curai Health, an AI-powered virtual clinic on a mission to improve access to care at scale. Anitha spearheads the development of machine learning technology designed to reimagine care delivery and enhance patient outcomes. Prior to her work at Curai, Anitha held senior research positions at Facebook AI Research and Microsoft Research, where she received multiple Gold Star awards. She holds a PhD in machine learning from the University of Toronto and was a Darwin Fellow at the University of Cambridge ..read more

Dr. Dan Heller leads the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center, where he develops advanced diagnostic technologies. His lab recently made headlines for creating a nanosensor "nose" that can sniff out ovarian cancer sooner than current tests. Using carbon nanotubes and machine learning, this artificial olfaction technology was able to identify ovarian cancer in early stages, making treatment more feasible. In addition to his pioneering work in the lab, Dr. Heller co-directs the Pat and Ian Cook Doctoral Program in Cancer Engineering at Memorial Sloan Kettering ..read more

Episode 32: Medical AI generalism and diabetic retinopathy, with RJ Kedziora, Co-founder of Estenda Solutions ..read more

Episode 31: AI for summarizing medical notes, with Vince Hartman, CEO of Abstractive Health ..read more

Felix is joined by Dr Antony Rix CEO of Lucida Medical, a company developing software for helping detect prostate cancer from MRI scans.  Between four and five million people are diagnosed with prostate cancer every year. Lucida Medical aims to distil expert radiologists' knowledge into AI driven tech, making diagnoses repeatable at any level of medical knowledge, slashing costs, and saving lives. Join me, Dr Felix Beacher, on today’s podcast we discuss the use of Artificial Intelligence (AI) technology in assessing prostate cancer with Dr Antony Rix, the CEO of Lucida Medical. Dr Rix sha ..read more

Felix is joined by Professor Runjan Chetty, Chief Medical Officer of Deciphex, a company developing AI-based diagnostics for pathology samples.  From neuropathology to skin pathology, from gynaecological pathology to gastrointestinal pathology, Professor Chetty and Deciphex aim to rapidly accelerate health care standards. In this episode of the podcast, join me, Dr Felix Beacher, as I sit down with Professor Runjan Chetty, CEO of Deciphex, a company focused on utilizing AI to improve the delivery of pathology services. Professor Chetty discusses how digitalized slides can revolutionize a ..read more